30 Stocks Moving in Friday s Pre-Market Session Benzinga 3 hrs ago
Gainers
Celcuity Inc. (NASDAQ: CELC) rose 32.3% to $19.00 in pre-market trading after the company reported a worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib. The company also reported preliminary data from Phase 1b Trial of gedatolisib plus ibrance and endocrine therapy for patients with ER+/HER2- metastatic breast cancer.
Gulf Resources, Inc. (NASDAQ: GURE) rose 29.5% to $6.02 in pre-market trading after the company reported a narrower loss for the fourth quarter.
TherapeuticsMD, Inc. (NASDAQ: TXMD) rose 19% to $1.57 in pre-market trading after the company, and Theramex, announced the approval of BIJUVE capsules indicated for hormone replacement therapy in the U.K. and under the trade name BIJUVA in Belgium.